HAL Gets a Buy Upgrade as Post-Earnings Signals Converge

Freedom Broker upgraded Halliburton to Buy on October 22, the day the company's Q3 results landed. The upgrade came with a $40 target, up from $37, implying 8% upside from the $33.99 close.

Analyst Moves Point the Same Way

The Freedom Broker move is the sharpest directional shift in a week of busy analyst activity. Sergey Pigarev raised both his rating and his target in one step. The day before, Jefferies lifted its target to $48 from $47 (Buy) and RBC Capital moved to $46 from $45 (Outperform). Barclays held its Overweight rating but trimmed its target to $51 from $53. UBS maintained Neutral and cut to $41 from $42 on the same day as the upgrade.

The consensus mean target stands at $43.68, which puts implied upside at roughly 29% from current levels. Every firm that moved this week held a positive rating. The direction of travel on targets is now clearly up, reversing the uniform cuts that followed the Q2 print in July.

The analyst recommendation differential factor scores at the 97th percentile, a reading that reflects how far ahead of sector peers the Street's collective stance sits on this name.

Defensive Options Positioning Into the Print

Options markets had been pricing in more caution ahead of the Q3 numbers. The put/call ratio hit 0.69 on October 20, 2.9 standard deviations above its 20-day mean of 0.62. That was the highest reading since late September. By October 21, the PCR had settled back to 0.67, still 1.6 standard deviations above the mean but no longer at the spike level. The 52-week range runs from 0.59 to 1.12, so the recent elevated reading sits well short of genuine extremes.

Q3 results triggered a 3.1% one-day move on October 20. The stock has gained 3.5% over the past week, roughly in line with peers: SLB is up 5.3%, RIG up 8.2%, and XPRO up 6.5% over the same period.

Borrow Costs and Short Positioning

The cost to borrow spiked 80% in one week to 0.41% around October 19, then settled to 0.46% as of October 21, up 60% over the past month. Despite the jump, the absolute level remains low. Borrow availability is essentially unconstrained: shares available to lend are running at 8,532% of current short interest, well above any level that would indicate pressure on bearish positions.

Short interest is 4.1% of the free float, up roughly 3.5% over the past week, a modest build after a sharper unwind in early October. At this level and with availability this loose, the borrow picture adds texture but is not the driving story.

Data Summary

• Upgrade: Freedom Broker, Hold to Buy, target raised to $40 from $37
• UBS maintained Neutral; cut target to $41 from $42
• Jefferies: Buy, target $48; RBC Capital: Outperform, target $46
• Consensus mean target: $43.68 (29% implied upside from $33.99)
• PCR: 0.67, 1.6 standard deviations above 20-day mean of 0.63
• Short interest: 4.1% of free float; borrow availability at 8,532%
• Cost to borrow: 0.46%, up 60% over one month but rated low in absolute terms
• Stock: +3.5% over the past week; +1.2% on October 21